Mycophenolate mofetil for Eczema

Overview
Mycophenolate mofetil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent rejection in organ transplant recipients. Mycophenolate mofetil is sometimes prescribed off-label to treat eczema. Mycophenolate mofetil is sold under the brand name CellCept.

Mycophenolate mofetil is an immunosuppressant. Mycophenolate mofetil is believed to work by inhibiting the growth of T cells and B cells, which contribute to inflammation in eczema.

How do I take it?
Mycophenolate mofetil is generally prescribed to be taken once daily.

Mycophenolate mofetil comes in tablet form.

Side effects
The FDA-approved label for mycophenolate mofetil lists common side effects including pain, fever, headache, infection, low blood cell count, urinary tract infection, hypertension, swelling, diarrhea, constipation, nausea, and infection.

Rare but serious side effects listed for mycophenolate mofetil include severe infections, birth defects, and increased risk for certain types of cancer.

For more details about this treatment, visit:

Mycophenolate Mofetil — Drugs.com
www.drugs.com/pro/mycophenolate-mofetil.html

Prescription Oral — National Eczema Association
www.nationaleczema.org/eczema/treatment/immunos...